144.75
-0.68
(-0.47%)
At close: January 13 at 3:54:55 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
4,408,000.00
3,784,000.00
4,259,000.00
4,616,000.00
3,477,000.00
Investing Cash Flow
-2,868,000.00
-1,892,000.00
-2,743,000.00
-1,578,000.00
-1,340,000.00
Financing Cash Flow
-713,000.00
-1,732,000.00
-1,555,000.00
-2,504,000.00
-1,522,000.00
End Cash Position
3,192,000.00
1,982,000.00
1,854,000.00
1,899,000.00
1,355,000.00
Capital Expenditure
-2,258,000.00
-2,023,000.00
-1,806,000.00
-1,421,000.00
-1,563,000.00
Issuance of Debt
1,202,000.00
1,216,000.00
2,918,000.00
859,000.00
6,437,000.00
Repayment of Debt
-1,821,000.00
-1,784,000.00
-3,506,000.00
-2,606,000.00
-7,272,000.00
Free Cash Flow
2,150,000.00
1,761,000.00
2,453,000.00
3,195,000.00
1,914,000.00
12/31/2020 - 8/3/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
29A.SG Amphastar Pharmaceuticals Inc
36.19
-0.74%
0ET.MU Esperion Therapeutics Inc
2.1980
0.00%
068760.KQ Celltrion Pharm, Inc.
55,900.00
-0.71%
SPBBF Speakeasy Cannabis Club Ltd.
0.0000
0.00%
R9U2.F Green Thumb Industries Inc.
7.00
-0.64%
EVT.VI Evotec SE
8.14
+1.06%
MB8.F Moberg Pharma AB (publ)
0.7665
+0.86%
SHMN SOHM, Inc.
0.0007
0.00%
CEL.L Celadon Pharmaceuticals Plc
16.00
0.00%
TEV.F Teva Pharmaceutical Industries Limited
20.10
+1.26%